Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
In: Breast Cancer Research and Treatment, Jg. 165 (2017-10-01), Heft 3, S. 573-583
Online
academicJournal
Zugriff:
Titel: |
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
|
---|---|
Autor/in / Beteiligte Person: | Nitz, Ulrike ; Gluz, Oleg ; Christgen, Matthias ; Kates, Ronald E. ; Clemens, Michael ; Malter, Wolfram ; Nuding, Benno ; Aktas, Bahriye ; Kuemmel, Sherko ; Reimer, Toralf ; Stefek, Andrea ; Lorenz-Salehi, Fatemeh ; Krabisch, Petra ; Just, Marianne ; Augustin, Doris ; Liedtke, Cornelia ; Chao, Calvin ; Shak, Steven ; Wuerstlein, Rachel ; Kreipe, Hans H. ; Harbeck, Nadia |
Link: | |
Zeitschrift: | Breast Cancer Research and Treatment, Jg. 165 (2017-10-01), Heft 3, S. 573-583 |
Veröffentlichung: | 2017 |
Medientyp: | academicJournal |
ISSN: | 0167-6806 (print) ; 1573-7217 (print) |
DOI: | 10.1007/s10549-017-4358-6 |
Sonstiges: |
|